Description
Topcon’s premier mydriatic retinal camera
Key features
- Easy to operate: touch control panel
- Easy focusing system
- Multi-modal fundus imaging
- Pan & tilt
Zewditu Building, Kolfe Keranyo Sub City, Addis Ababa, Ethiopia
Topcon’s premier mydriatic retinal camera
Topcon’s premier mydriatic retinal camera
There are no reviews yet.
Rapidly developing technical advancements in digital cameras have led to retinal imaging with higher resolutions and newer capturing methods. Topcon’s TRC-50DX retinal cameras incorporate state-of-the-art sensors that enhance versatility, image quality, and operational ease. The TRC-50DX offers multimodal fundus imaging including color, red-free, and fluorescein angiography (FA) while the Topcon TRC-50DX (Type IA) can also perform indocyanine green (ICG1 ) and fundus autofluorescence (FAF ).
1 Optional filter can let the operator add or exchange them to accommodate different procedures.
Fundus autofluorescence (FAF1) is a non-invasive technique to acquire images of the retina by visualizing the autofluorescence of lipofuscin within the retinal pigment epithelium (RPE). The Topcon-exclusive, Spaide FAF filters2 are optimized for the observation of lipofuscin deposits in the retina as they require 40% less illumination than conventional FAF1 filters3.
The Flash Intensity Control* has 21 levels and can be used in full or half steps. Sensitive membrane buttons permit total control of image brightness and are illuminated for use in subdued light.
*Light Source: For photography: Max300ws Xenon
Green alignment dots provide easy confirmation of the working distance of the objective lens alignment. These dots are helpful for pre-injection positioning in fluorescein angiography (FA), red-free, and color fundus photography.
Quality Medical Equipment for Ethiopia! Our mission is to provide first-class independent healthcare equipment for the local community in a safe, comfortable, and welcoming manner.
Copyright © HBL plc. Website Design by Addis Tech Group
Reviews
There are no reviews yet.